Check the time stamp on this data. Updated AI-Generated Signals for Sage Therapeutics Inc. (SAGE) available here: SAGE.

Sage Therapeutics, Inc. SAGE reported a loss of $1.53 per share for the third quarter of 2024, wider than the Zacks Consensus ...

Sage (SAGE) stock fell 18% post-market after the company released its Q3 earnings report and said it was ending development ...

Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $1.52. This compares to loss of $2.81 per share a year ago.

Good afternoon. Welcome to Sage Therapeutics’ Third Quarter 2024 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the ...

SAGE Therapeutics, Inc. (US) ( (SAGE) ) has realeased its Q3 earnings. Here is a breakdown of the information SAGE Therapeutics, Inc. (US) ...

We put the Sage Precision Brewer Thermal to the test, to see if its tech guidance makes it easier to get the perfect morning ...

Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $1.52. This compares to loss of $2.81 per share a year ago. These ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Sage Therapeutics, Inc. (SAGE) reports results for the quarter ended September 2024. While this widely-known ...

Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of an overhaul of its business and pipeline that’s expected to ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Sage Therapeutics, Inc. (SAGE) reports results for the quarter ended September 2024. While this widely-known consensus ...